Read latest Pharmaceutical News when a major Pharmaceutical scoop arises.
New Delhi, Nov 3 : Pharmaceutical major Lupin Monday said that it has received final approvals for its anti-arthritis medicine Celecoxib Capsules by the US Food and Drugs Administration (FDA).
New Delhi, Nov 1 : Global healthcare company Eli Lilly and Company completed the technology transfer of multi-drug resistant tuberculosis (MDR-TB) drug Cycloserine in India to Shasun Chemicals and Drugs Ltd. Chennai, the company said here.
Tokyo, Oct. 31 : Fujifilm Corporation announced that the anti-influenza drug Avigan Tablet 200mg' *(Favipiravir), developed by the Fujifilm Group company Toyama Chemical Co., Ltd, has been administered to a patient infected with the Ebola virus disease at a hospital in France.
Jerusalem, Oct 30 : Leslie Lobel, a virologist at Israel's Ben-Gurion University, is not surprised by the current epidemic of the Ebola virus disease in West Africa and says that sooner or later it would have happened.
Hyderabad, Oct 29 : Pharmaceutical major Dr Reddy's Laboratories Limited has reported 17 percent decline in net profit during the second quarter ended September, at Rs.574.10 crore against Rs.690.25 crore in the corresponding quarter last year.
New Delhi, Oct 16 : Drugmaker Ranbaxy Laboratories Thursday said it has settled the litigation concerning its participation in the Texas Medicaid Program and agreed to pay $39.75 million.
By Ashok Dixit, New Delhi, Oct. 15 : Eminent academic, medicinal chemist and pharmaceutical historian Professor Harkishan Singh's autobiography "Witness to an Era" traces an over six-decade-long journey from a forgotten India of the 1940s, when a majority of people in its northern parts overcame the mayhem of partition to emerge as success stories, to a 21st century information technology-driven nation to be proud of.
New Delhi, Oct 15 : Health-care major Abbott Wednesday opened its new greenfield nutrition manufacturing plant in Jhagadia, Gujarat, which has come up with an investment of Rs.450 crore ($75 million).
New Delhi, Sep 23 : The government has withdrawn the regulator, National Pharmaceutical Pricing Authority's (NPPA) powers of fixing the prices of non-essential medicines.
Chennai, Sep 17 : In an $80 million deal, India's pharmaceutical major Sun Pharmaceutical Industries Ltd. will acquire worldwide rights to US-based Merck & Co Inc's tildrakizumab, an investigational therapeutic antibody candidate, the company said.
Hyderabad, Sep 16 : Global pharmaceuticals and consumer packaged goods manufacturer Johnson and Johnson's biggest manufacturing facility in India is set to come up in Telangana with an investment of Rs.400 crore.
Mumbai, Sep 16 : Pharma major Lupin Tuesday entered into a long-term strategic partnership with Germany-based biopharmaceutical firm Merck Serono for expansion of its portfolio initiative in emerging markets.
New Delhi, Sep 4 : The Competition Commission of India (CCI) Thursday invited comments from all stakeholders, including the general public, on the merger of pharma companies Ranbaxy Laboratories and Sun Pharmaceutical Industries, signalling the first public scrutiny of a merger and acquisition (M&A) agreement in the country.
New York, Aug 26 : An Indian-origin researcher at Michigan Technological University has deciphered how Glycoconjugates - biomolecules that hold sugars in the body like scaffolds for reacting with other molecules - can lead to new and better drugs.
Washington, Aug 13 : Ebola drugs that are currently being used to treat some patients in the West Africa are ethically sound, say the World Health Organization officials.
Kolkata, Aug 12 : The central government's decision to introduce rotavirus vaccine in India's Universal Immunization Programme can reduce as many as 26,985 deaths annually due to rotaviral diarrhoea, a study said.
Washington, Aug 7 : Mass production of an experimental drug given to two US aid workers with Ebola may take "several months", the US manufacturer said Wednesday.
Chennai, Aug 6 : Drug major Lupin Ltd Wednesday announced its agreement with South Korean company LG Life Sciences to source and market in India diabetic medicine Insulin Glargine under the brand Basugine.
Chennai, July 31 : City-based medical technology company Cura Healthcare has turned acquisitive to enter the ultrasound equipment segment by buying diagnostic imaging company DE Healthcare, said a top company official.
Washington, July 24 : A new study has revealed paracetamol is no better than Placebo as it does not help in speedy recovery from severe lower back pain or improving pain levels, function, sleep, or quality of life.
By Rajnish Singh, New Delhi, July 24 : After cannabis and heroin, the misuse of pharmaceutical drugs is rising among subcontinental drug users because of their easy availability at cheap rates and this is a cause for concern, a top UN official has said.
Thiruvananthapuram, July 18 : Scientists at HLL Life Care here are not entering the multi-billion dollar business of sexual wellness products as they work on the next generation of male contraceptive, a senior official said Friday.
By Francis Kokutse, Accra, July 13 : As Indian pharmaceutical companies prepare to increase the volume of their trade in Nigeria, it is becoming clear that they would have to compete companies from their closest neighbour, Pakistan, which have given the signal that they are keen to take a slice of Nigeria's growing market in the health sector as well as pharmaceutical products.
Chennai, July 3 : City-based medical technology company Cura Healthcare is looking at developing countries for its products, said a top company official.
Hyderabad, July 1 : BITS Pilani-Hyderabad has developed a new low-cost, ultra-rapid portable device to test antibiotic sensitivity of human urinary pathogens which can help curb antibiotic resistance to a large extent.
Bangalore, June 23 : Kiran Mazumdar-Shaw, Chairperson and Managing Director of Biocon Ltd, Asia's leading bio-pharmaceutical company, has been awarded the Kiel Institute's most coveted '2014 Global Economy Prize' for business during the 100th anniversary celebrations of the Institute held in Kiel, Germany on Sunday, June 22.
New Delhi, June 17 : Two global pharmaceutical firms - Hilleman Laboratories and Gotovax AB - Tuesday joined hands to develop affordable oral cholera vaccine.
Bangalore, May 26 : The International Finance Corporation (IFC) of the World Bank is lending USD 147.5 million (Rs.863 crore) to Jubilant Pharma, a Singapore-based subsidiary of drug major Jubilant Life Sciences, to ensure access to affordable drugs in underserved markets in India and other countries.
New Delhi, May 21 : The Supreme Court Wednesday asked the Andhra Pradesh High Court to decide in two days the issues that have been raised to stall the amalgamation of Ranbaxy Laboratories Limited with Sun Pharmaceutical Industries Limited following a USD 4 billion takeover deal.
Kolkata, May 8 : HealthCare Global (HCG) Enterprises Ltd, the Specialists in Cancer Care on Thursday announced genomics-based diagnostics, a 'standard-of-care' for cancer treatment in India.
Bangalore, May 7 : Healthcare analytics and population health company Caradigm recently signed a business cooperation agreement with analytic process integrator Symphony Analytics, to help healthcare providers rapidly improve clinical and financial outcomes through comprehensive healthcare analytics solutions. Under the agreement, Symphony Analytics will provide strategic consulting and implementation services to healthcare providers adopting the Caradigm Intelligence Platform and Caradigm analytics applications, including Caradigm Readmissions Management.
Hyderabad, May 5 : Sanofi Pasteur, the vaccines division of Sanofi on Monday announced that its pediatric pentavalent vaccine Shan5, developed and manufactured by its affiliate Shantha Biotechnics in Hyderabad, has received prequalification status from the World Health Organization (WHO).
Hyderabad, May 5 : Shan5, a paediatric pentavalent or five-in-one vaccine developed by Hyderabad-based Shantha Biotechnics, an arm of Sanofi Pasteur, the vaccines division of French pharmaceutical company Sanofi, has regained prequalification status from the World Health Organisation (WHO).
New Delhi, May 3 : India can be a global leader in supplying affordable and high quality medicines to the world, and especially to the underdeveloped countries where such medicines do not reach the poor because of their high cost and the monopoly of foreign manufacturers, said a leading entrepreneur.
Washington, Apr 21 : US based pharmaceutical company Pfizer has proposed to take over its British rival AstraZeneca for 60 billion pounds (101 billion dollars).
Mumbai, Apr 14 : The importers and manufacturers of dietary supplements, health supplements, functional foods and nutraceutical industry have deplored the alleged ambiguous scheme of 'Product Approval' by the Food Safety and Standards Authority of India (FSSAI), despite having a stay order from the Bombay High Court for 6 months.
London, April 11 : Oxilofrine, found in the dietary supplement of former world record holder in the 100 m Asafa Powell, is a stimulant drug banned by the World Anti-Doping Agency.
Mumbai, Apr. 7 : Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories Ltd has announced that they have entered into definitive agreements pursuant to which Sun Pharma will acquire 100 per cent of Ranbaxy in an all-stock transaction.
New Delhi, April 7 : India's largest drugmaker by market capitalisation Sun Pharma will buy out Japan's Daiichi-controlled Ranbaxy Laboratories for USD 4 billion in an all-share deal, the two companies said Monday.
Mumbai, Apr 3 : Venus Remedies Ltd, a research-based global pharmaceutical company, has extended its footprint in Latin America with marketing authorisation for meropenem from Venezuela, a USD 6-billion pharmaceutical market.
Bangalore, March 24 : Indian pharma major Jubilant Life Sciences Ltd's subsidiary Chemsys will develop new drugs in collaboration with a US-based research institute to combat tuberculosis in the Indian subcontinent.
Bangalore, March 24 : Chemsys, a subsidiary of Indian pharma major Jubilant Life Sciences Ltd, has got an additional USD 3.4 million (Rs.21 crore) from a US-based research institute to develop new drugs for combating tuberculosis (TB) in the sub-continent, it was announced Monday.
New Delhi, Mar.18 : While recent developments in Ukraine have had no immediate impact on the businesses of leading Indian pharmaceutical companies based in Ukraine, it is felt that if the situation continues then it could have a bearing on the country's exchange rate that would make the landed cost of Indian pharmaceuticals higher.
Bangalore, Mar 13 : Strand Life Sciences (Strand), a Bangalore and San Francisco-based bioinformatics and systems biology company has received patent protection for its "method for predicting organ toxicity and a system thereof" in the United States (USPTO patent no. 8,645,075) effective from Feb 4.
New Delhi, March 10 : Stressing that India's pharmaceutical technology was appropriate for Africa, Commerce Minister Anand Sharma said India is committed to making available to developing countries newer generation life-saving drugs also.
New Delhi, Feb 26 : Drug maker Lupin Wednesday said it has received final approval from the US health regulator to market the generic version of Mycobutin capsules of Pharmacia and Upjohn Company used in treating advance HIV infection.
New Delhi, Feb 25 : India's largest drug maker Ranbaxy Laboratories Tuesday said it has halted temporarily drug ingredient production at two of its facilities in the country as a "precautionary measure".
New York, Feb 19 : India's Ranbaxy Laboratories and Israel's Teva pharmaceutical Industries are set to settle over allegations that the two rival generic drug makers made an unlawful agreement to restrict competition, according to a media report.
Mumbai, Feb 16 : The Britain-based GlaxoSmithKline Plc's voluntary open offer to the shareholders of its Indian subsidiary GlaxoSmithKline Pharmaceuticals (GSK Pharma) is scheduled to start Tuesday.
Bangalore, Feb 10 : Pharma major Cipla chairman Yusuf Hamied Monday donated Rs.8 crore to support a chemistry education programme in Indian schools by the Britain-based Royal Society of Chemistry.
Gurgaon/ Tokyo,Feb.5 : The Board of Directors of Ranbaxy Laboratories Limited at its meeting held today, took on record the unaudited results for the Quarter and YTD ended December 31, 2013 under Indian GAAP.
Bangalore, Jan 29 : British pharma major AstraZeneca plc Wednesday announced the closing of its research and development (R and D) centre here but said it will continue manufacturing and marketing operations in India.
By Arun Kumar, Washington, Jan 24 : In another setback to Ranbaxy, the US drug regulator has prohibited the Indian drugmaker from producing and distributing drugs for the US market from its Toansa facility in Punjab.
Kolkata, Jan 17 : The Department of Pharmaceutical Technology, Jadavpur University along with the NSHM Knowledge Campus Group of Institutions and Indian Association of Pharmaceutical Scientists and Technologists (IAPST) on Friday hosted the 2nd Pharma Tech IAPST International Conference, here.